ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,996Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 1111

$576K Total Retail Price of All Prescriptions

Rank: 167 out of 1111

352 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 352 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 352 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 10,288 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
OMEPRAZOLE 582 451 1 4
FUROSEMIDE 496 471 2 6
SIMVASTATIN 472 391 3 5
POTASSIUM CHLORIDE 447 416 4 9
LEVOTHYROXINE SODIUM 381 354 5 3
HYDROCODONE-ACETAMINOPHEN 372 327 S3 6 1
CARVEDILOL 271 246 7 21
WARFARIN SODIUM 255 254 8 19
PRAVASTATIN SODIUM 252 220 9 17
METOPROLOL TARTRATE 247 222 10 12
MIRTAZAPINE 244 232 11 52
AMLODIPINE BESYLATE 242 217 12 7
LISINOPRIL 224 201 13 2
DONEPEZIL HCL 214 203 14 25
POLYETHYLENE GLYCOL 3350 199 181 15 45
ZOLPIDEM TARTRATE 182 154 16 16
CITALOPRAM HBR 163 140 17 14
NAMENDA 150 126 18 31
ALLOPURINOL 148 140 19 36
HYDROCHLOROTHIAZIDE 146 71 20 11
GABAPENTIN 144 132 21 10
ENALAPRIL MALEATE 140 127 22 56
FAMOTIDINE 138 126 23 77
PAROXETINE HCL 134 132 24 55
METFORMIN HCL 131 93 25 8
TRAZODONE HCL 122 108 26 32
DIGOXIN 122 113 26 47
CRESTOR 113 89 28 33
CLOPIDOGREL 108 108 29 30
ALENDRONATE SODIUM 106 100 30 35
FENTANYL 92 71 S2 31 65
ATENOLOL 86 61 32 22
TAMSULOSIN HCL 85 72 33 28
SPIRONOLACTONE 84 71 34 83
QUETIAPINE FUMARATE 83 83 35 76
METOPROLOL SUCCINATE 80 43 36 20
ATORVASTATIN CALCIUM 79 76 37 15
MELOXICAM 77 76 38 18
CELEBREX 74 61 39 81
PEN NEEDLE 70 70 40 207
LOSARTAN POTASSIUM 67 56 41 34
ALBUTEROL SULFATE 67 53 41 136
PANTOPRAZOLE SODIUM 64 52 43 50
FLUTICASONE PROPIONATE 62 51 44 27
TRAMADOL HCL 61 59 45 13
PLAVIX 60 60 46 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 44 47 23
GLIPIZIDE 58 50 47 57
CARBIDOPA-LEVODOPA 57 57 49 101
CEFTRIAXONE 56 51 50 281
ESTRADIOL 55 25 R 51 102
SUCRALFATE 54 54 52 125
NOVOLIN R 54 37 52 142
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 49 54 71
RISPERIDONE 53 51 54 60
LANTUS 53 41 54 46
METOCLOPRAMIDE HCL 52 38 57 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.